Research Division

Transforming Science into Improved Patient Care

Research at Hospital for Special Surgery is focused on identifying mechanisms underlying musculoskeletal and autoimmune conditions, and discovering and developing effective approaches for prevention, diagnosis, and treatment of orthopedic and rheumatic diseases.

  • More than 200 scientists and staff work on bench-to-bedside research on tissue degeneration, autoimmunity, biomechanics, bone biology, and tissue repair.  
  • Research is supported by more than $30 million annually in funding from the National Institutes of Health, foundations, industry, and philanthropy.
  • Multidisciplinary teams of basic scientists, biomedical engineers, and clinical investigators collaborate to define mechanisms involved in osteoarthritis, cartilage repair, lupus, and bone injury and regeneration.
  • More than 30 registries spanning orthopaedic and rheumatologic conditions collect data on patient demographics, disease and surgery details, and treatment and clinical outcomes on the more than 24,000 surgeries and 265,000 patient visits each year.
^ Back to Top


  • Dr. Mary Goldring Named President of Orthopaedic Research Society

    Dr. Mary Goldring, senior scientist at Hospital for Special Surgery (HSS) in New York City, has been named president of the Orthopaedic Research Society (ORS). The inauguration took place at the organizationís annual meeting on March 17 in New Orleans, with more than 2600 attendees. Learn More.

  • Improving Patient Outcomes Through Registries

    Registries provide the foundation for clinical trials, translational research, and treatment innovation. HSS has created more than 30 registries including the Hip, Knee and Shoulder Arthroplasty Registries, Sports Medicine and Shoulder Services ACL Registry, Center for Hip Preservation Registry, Autoimmune Disease Registry, and Scleroderma Registry. Read more and learn how to participate

  • Saving Pregnancies in Women with Lupus

    Jane Salmon, MD is Principal Investigator on a multi-center NIH-funded research initiative, the PROMISSE study, to identify predictors of poor pregnancy outcomes in women with systemic lupus erythematosus (SLE). The study is providing insights on the genes and cellular pathways that can affect pregnancy in lupus patients and, potentially, cause miscarriage and preeclampsia in healthy women. Learn more

Request an Appointment